SCHEMBL1704752

SCHEMBL1704752

[CH2]Cc1c[nH]c2ccc(Cl)cc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.73
HTR2A P28223 4/20 0.65
TRPM8 Q7Z2W7 1/20 0.65
SLC6A4 P31645 3/20 0.60
HTR1A P08908 1/20 0.56
ADRA2A P08913 1/20 0.56
DRD2 P14416 1/20 0.56
ADRA2B P18089 1/20 0.56
ADRA2C P18825 1/20 0.56
SLC6A2 P23975 1/20 0.56
ADRA1D P25100 1/20 0.56
HTR1D P28221 1/20 0.56
HTR1B P28222 1/20 0.56
HTR2C P28335 1/20 0.56
HTR1E P28566 1/20 0.56
HTR7 P34969 1/20 0.56
ADRA1A P35348 1/20 0.56
HRH1 P35367 1/20 0.56
ADRA1B P35368 1/20 0.56
OPRM1 P35372 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28837438 0.86 HTR2A (0.71) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL2404863 0.85 GPR84 (0.73) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL18383117 0.85 GPR84 (1.00) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL949791 0.83 GPR84 (0.76) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL892446 0.81 HTR2A (0.75) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL26498347 0.81 GPR84 (0.73) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL7599108 0.81 GPR84 (0.73) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL31567582 0.81 GPR84 (0.73) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL10119751 0.81 GPR84 (0.73) GPR84HTR2ATRPM8SLC6A4HTR1A
SCHEMBL15676249 0.81 HTR2A (0.69) GPR84HTR2ATRPM8SLC6A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440550-A1 INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-04-18 EP disclosed